… While randomized controlled trials are conducted to assess the efficacy and safety of …
have been shown to be lower than efficacy estimates from randomized controlled trials [Citation26]. …

… tested in this study, six 25-mg tablets and one 150-mg tablet, are bioequivalent, so
plasma exposure and efficacy will not be affected if 25-mg tablets are substituted for a dose. …

… On the basis of the in vitro data described above, we hypothesized that reduced-dose
erlotinib has similar efficacy to the MTD of erlotinib and represents a viable treatment option for …

… erlotinib maintenance therapy was given, the use of pemetrexed and docetaxel increased in
2nd-line therapy due to our assumption that patients would not be given erlotinib in … efficacy …

… be efficacious. Nonclinical evidence from NSCLC xenograft models suggests that sunitinib
increases the antitumor activity of erlotinib. … the efficacy and safety of sunitinib plus erlotinib in …

… explored the efficacy and safety of VEGF neutralizing antibodies, combined with erlotinib. …
was to explore the efficacy and safety of combined medications, and simultaneously to conduct …

… the closely related EGFR tyrosine kinase inhibitor erlotinib. Erlotinib 150 mg daily was more
… it was important to establish the efficacy of erlotinib monotherapy with a phase 2 single-arm …

… Erlotinib is an … of erlotinib in patients with advanced NSCLC who had progressed after
standard chemotherapy treatment was conducted to examine the efficacy and safety of erlotinib …

… Bevacizumab and erlotinib target different tumour growth … of erlotinib plus bevacizumab
for recurrent or refractory non-small-cell lung cancer (NSCLC), we aimed to assess efficacy and …

… or pemetrexed and intermitted erlotinib with single-agent erlotinib in second-line treatment
of NSCLC are available in the current literature. The increased efficacy of combining these …